Successful treatment of axillary hyperhidrosis with very low doses of botulinum toxin B: a pilot study

被引：0
|
作者：
Martin J. Hecht
Frank Birklein
Martin Winterholler
机构：
[1] University of Erlangen-Nuremberg,Department of Neurology
[2] University of Mainz,Department of Neurology
[3] Krankenhaus Rummelsberg,Department of Neurology
来源：
Archives of Dermatological Research | 2004年 / 295卷
关键词：
Botulinum toxin B; Axillary hyperhidrosis; Sweating; Autonomic nervous system;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：318 / 319
页数：1
相关论文
共 50 条
  • [41] Comparison of intradermal injection with iontophoresis of abobotulinum toxin A for the treatment of primary axillary hyperhidrosis: A randomized, controlled trial
    Montaser-Kouhsari, Laleh
    Zartab, Hamed
    Fanian, Ferial
    Noorian, Negin
    Sadr, Bardia
    Nassiri-Kashani, Mansour
    Firooz, Alireza
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2014, 25 (04) : 337 - 341
  • [42] Experience with botulinum toxin therapy for axillary hyperhidrosis and comparison to modelled data for endoscopic thoracic sympathectomy - A quality of life and cost effectiveness analysis
    Gibbons, John P.
    Nugent, Emmeline
    O'Donohoe, Nollaig
    Maher, Barry
    Egan, Bridget
    Feeley, Martin
    Tierney, Sean
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2016, 14 (05): : 260 - 264
  • [43] Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival
    Campanati, A.
    Sandroni, L.
    Gesuita, R.
    Giuliano, A.
    Giuliodori, K.
    Marconi, B.
    Ganzetti, G.
    Offidani, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (08) : 917 - 921
  • [44] Botulinum toxin type B for treatment of spasmodic dysphonia: A case report
    Sataloff, RT
    Heman-Ackah, YD
    Simpson, LL
    Park, JB
    Zwislewski, A
    Sokolow, C
    Mandel, S
    JOURNAL OF VOICE, 2002, 16 (03) : 422 - 424
  • [45] Correlation between Dermatology Life Quality Index and Minor Test and Differences in Their Levels over Time in Patients with Axillary Hyperhidrosis Treated with Botulinum Toxin Type A
    Skroza, Nevena
    Bernardini, Nicoletta
    La Torre, Giuseppe
    La Viola, Giorgio
    Potenza, Concetta
    ACTA DERMATOVENEROLOGICA CROATICA, 2011, 19 (01) : 16 - 20
  • [46] Pharmacologic effects of myobloc® (botulinum toxin type B, BoNT/B) on rat salivary gland:: A doseranging study
    Salazar-Grueso, Edgar
    Reinhard, Sharon
    TOXICON, 2008, 51 : 19 - 20
  • [47] Botulinum Toxin A Versus B in Sialorrhea: A Prospective, Randomized, Double-Blind, Crossover Pilot Study in Patients with Amyotrophic Lateral Sclerosis or Parkinson's Disease
    Guidubaldi, Arianna
    Fasano, Alfonso
    Ialongo, Tamara
    Piano, Carla
    Pompili, Maurizio
    Masciana, Roberta
    Siciliani, Luisa
    Sabatelli, Mario
    Bentivoglio, Anna Rita
    MOVEMENT DISORDERS, 2011, 26 (02) : 313 - 319
  • [48] The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: Summary of three controlled clinical trials
    Lew, MF
    Brashear, A
    Factor, S
    NEUROLOGY, 2000, 55 (12) : S29 - S35
  • [49] Long-term efficacy and respective potencies of botulinum toxin A and B: a randomized, double-blind study
    Kranz, G.
    Paul, A.
    Voller, B.
    Posch, M.
    Windischberger, C.
    Auff, E.
    Sycha, T.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 164 (01) : 176 - 181
  • [50] Successful treatment of Raynaud's phenomenon and digital ulcers in systemic sclerosis patients with botulinum toxin B injection: Assessment of peripheral vascular disorder by angiography and dermoscopic image of nail fold capillary
    Motegi, Sei-ichiro
    Sekiguchi, Akiko
    Saito, Shintaro
    Ishibuchi, Hirohisa
    Kishi, Chikako
    Yasuda, Masahito
    Ishikawa, Osamu
    JOURNAL OF DERMATOLOGY, 2018, 45 (03) : 349 - 352
12345